Literature DB >> 6436516

Human adult endothelial cell growth in culture.

B Jarrell, E Levine, S Shapiro, S Williams, R A Carabasi, S Mueller, S Thornton.   

Abstract

The purpose of the present study was to culture human adult endothelial cells (HAECs) on a long-term basis in the laboratory. Previous inability to accomplish this has been the major impediment to the in vitro study of endothelialization of prosthetic grafts with human cells, a problem of significant clinical relevance. We have been successful in developing a technique that allows HAECs from human adult arteries, veins, and capillaries to proliferate vigorously in culture for up to 80 population doublings. HAECs are grown on a gelatin surface (medium 199 containing 20% fetal calf serum). Heparin and endothelial cell growth factor (ECGF) are required for optimal growth. With this technique, which will be described in detail, over 10(23) HAECs can be produced from each 1 cm2 of vascular tissue. This makes large numbers of HAECs available for high-density seeding on prosthetic grafts prior to implantation. It also permits for the first time with human cells the in vitro study of prosthetic grafts--HAEC interactions and the factors that enhance optimal growth and adherence to prosthetic materials. It is hoped that identification of the factors promoting graft endothelialization in combination with high-density seeding will lower graft thrombogenicity and therefore result in greater graft longevity than has been possible heretofore.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6436516     DOI: 10.1067/mva.1984.avs0010757

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  16 in total

1.  Selective cell proliferation can be controlled with CPC particle coatings.

Authors:  J A Szivek; D S Margolis; A B Schnepp; W A Grana; S K Williams
Journal:  J Biomed Mater Res A       Date:  2007-06-15       Impact factor: 4.396

2.  Serial subculture and relative transport of human endothelial cells in serum-free, defined conditions.

Authors:  T L Weiss; S E Selleck; M Reusch; B U Wintroub
Journal:  In Vitro Cell Dev Biol       Date:  1990-08

3.  Effects of interleukin-1, lipopolysaccharide, and streptococci on procoagulant activity of cultured human cardiac valve endothelial and stromal cells.

Authors:  T A Drake; M Pang
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

4.  Identification and characterization of cell-substratum adhesion receptors on cultured human endothelial cells.

Authors:  S M Albelda; M Daise; E M Levine; C A Buck
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

5.  Adherence of alloreactive lymphocytes to human arterial endothelial cell monolayers.

Authors:  Y L Colson; B H Markus; A Zeevi; R J Duquesnoy
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

6.  Isolation, growth requirements, cloning, prostacyclin production and life-span of human adult endothelial cells in low serum culture medium.

Authors:  H Hoshi; W L McKeehan
Journal:  In Vitro Cell Dev Biol       Date:  1986-01

7.  Perspectives in vascular surgery--biocompatible vascular surfaces: the past and future role of endothelial cells.

Authors:  B E Jarrell; S K Williams; J R Hoch; R A Carabasi
Journal:  Bull N Y Acad Med       Date:  1987-03

8.  Use of an endothelial monolayer on a vascular graft prior to implantation. Temporal dynamics and compatibility with the operating room.

Authors:  B E Jarrell; S K Williams; L Solomon; L Speicher; E Koolpe; J Radomski; R A Carabasi; D Greener; F E Rosato
Journal:  Ann Surg       Date:  1986-06       Impact factor: 12.969

9.  Venular endothelium in vitro: isolation and characterization.

Authors:  C F Moyer; P A Dennis; G Majno; I Joris
Journal:  In Vitro Cell Dev Biol       Date:  1988-04

10.  Interleukin-12 inhibits tumor growth in a novel angiogenesis canine hemangiosarcoma xenograft model.

Authors:  Nasim Akhtar; Marcia L Padilla; Erin B Dickerson; Howard Steinberg; Matthew Breen; Robert Auerbach; Stuart C Helfand
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.